Premenstrual Syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: To the intervention group, an average glass of Achmoravan extract containing 300 µg of active ingredient in Qazvin Ghazvin Flower Company (three times a day for 7 days late luteal phas
Treatment - Drugs
To the intervention group, an average glass of Achmoravan extract containing 300 µg of active ingredient in Qazvin Ghazvin Flower Company (three times a day for 7 days late luteal phase) was given to
To the control group, routine therapy usually used by people of their choice (it should be noted that due to the repeated recurrence of this problem, the overwhelming majority of patients with each cy
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
15 Years to 49 Years
Inclusion criteria
Inclusion criteria: The criteria for entering the study include regular menstruation with intervals of 24-35 days; a natural body mass index of 19.86 - 26.6; no physical or mental illness or drug use; non-use of hormonal drugs and prevention of hormonal contractions and vitamins and anti seizures and antidepressants in the last 3 months; having symptoms in the second half of the cycle; having symptoms in three consecutive cycles and not smoking.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Premenstrual Syndrome. Timepoint: Each month for 9 months. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactResearch Deputy of Qazvin University of Medical Sciences. Dr. Fatemeh Mohammadi
Qazvin University of Medical Sciences
Outcome results
None listed